These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19659563)

  • 21. Late onset OCD.
    Bhattacharyya S; Khanna S
    Aust N Z J Psychiatry; 2004 Jun; 38(6):477-8. PubMed ID: 15209842
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Obsessive compulsive disorder and schizophrenia. An attempt at psychopathologic differentiation by focusing on the single phenomenon of obsession].
    Bürgy M
    Nervenarzt; 2005 Nov; 76(11):1370-5. PubMed ID: 15756529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Musical obsessions in obsessive-compulsive disorder].
    Matta AP; Ribas MC; Carod-Artal FJ
    Rev Neurol; 2012 Apr; 54(8):508-9. PubMed ID: 22492104
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine.
    Biondi M; Fedele L; Arcangeli T; Pancheri P
    Psychother Psychosom; 1999; 68(2):111-2. PubMed ID: 10026463
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
    Flament MF; Bisserbe JC
    J Clin Psychiatry; 1997; 58 Suppl 12():18-22. PubMed ID: 9393392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
    Landeros-Weisenberger A; Bloch MH; Kelmendi B; Wegner R; Nudel J; Dombrowski P; Pittenger C; Krystal JH; Goodman WK; Leckman JF; Coric V
    J Affect Disord; 2010 Feb; 121(1-2):175-9. PubMed ID: 19577308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
    Fineberg NA; Bullock T; Montgomery DB; Montgomery SA
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract]   [Full Text] [Related]  

  • 30. The first Japanese pediatric case of obsessive-compulsive disorder who responded to a selective serotonin re-uptake inhibitor.
    Furusho J; Kubagawa T; Saitoh N; Matsuzaki K; Yamakawa H; Iikura Y
    Pediatr Int; 2000 Aug; 42(4):451-2. PubMed ID: 10986886
    [No Abstract]   [Full Text] [Related]  

  • 31. [Obsessive-compulsive disorder in childhood and adolescence].
    Hoshino Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):106-10. PubMed ID: 14626078
    [No Abstract]   [Full Text] [Related]  

  • 32. The Stuck Song Syndrome: A Case of Musical Obsessions.
    Orjuela Rojas JM; Lizarazo Rodríguez IL
    Am J Case Rep; 2018 Nov; 19():1329-1333. PubMed ID: 30401794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Mundo E; Bianchi L; Bellodi L
    J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obsessional jealousy: unusual presentation.
    Agarwal AL; Sharma V; Biswas D
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1068. PubMed ID: 19016096
    [No Abstract]   [Full Text] [Related]  

  • 36. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
    Andrade C
    J Clin Psychiatry; 2012 Nov; 73(11):e1362-4. PubMed ID: 23218164
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluvoxamine in the treatment of corticosteroid-induced obsessive-compulsive disorder.
    Oulis P; Masdrakis VG; Florakis A; Papadimitriou GN
    Clin Neuropharmacol; 2009; 32(3):176-7. PubMed ID: 19483493
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacotherapy of primary obsessive-compulsive disorder: review of the literature.
    Ellingrod VL
    Pharmacotherapy; 1998; 18(5):936-60. PubMed ID: 9758307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.